Fineline Cube

Follow:
14409 Articles
Sprint-Bioscience Sells TREX1 Program to Gilead for $14M Upfront
CompanyDeals

Sprint-Bioscience Sells TREX1 Program to Gilead for $14M Upfront

Novo Nordisk's Semaglutide 7.2 mg sNDA Submitted for Weight Management
CompanyDrug

Novo Nordisk’s Semaglutide 7.2 mg sNDA Submitted for Weight Management

CSPC's JMT206 Wins NMPA Nod for ActRII-Targeted Weight Management
CompanyDrug

CSPC’s JMT206 Wins NMPA Nod for ActRII-Targeted Weight Management

MicroTech's LinX CGM Wins India Approval, Expanding Asia Diabetes Monitoring
CompanyMedical Device

MicroTech’s LinX CGM Wins India Approval, Expanding Asia Diabetes Monitoring

Bio-heart's IberiRDN Wins New Zealand Nod as Only Dual-Approach Renal Denervation System
Medical Device

Bio-heart’s IberiRDN Wins New Zealand Nod as Only Dual-Approach Renal Denervation System

IASO-Bio's Fucaso Wins Hong-Kong Approval as First China CAR-T
CompanyDrug

IASO-Bio’s Fucaso Wins Hong-Kong Approval as First China CAR-T

BeOne's Sotoclax Wins FDA Priority Review for Mantle Cell Lymphoma
CompanyDrug

BeOne’s Sotoclax Wins FDA Priority Review for Mantle Cell Lymphoma

Patronus Biotech Gates Foundation Grant Accelerates Malaria Vaccine Development
CompanyDeals

Patronus Biotech Gates Foundation Grant Accelerates Malaria Vaccine Development

Innova Therapeutics Acquires Enci Therapeutics' IVT-8086 Cancer Program
CompanyDeals

Innova Therapeutics Acquires Enci Therapeutics’ IVT-8086 Cancer Program

Gene Key's iNKT Cell Therapy Wins NMPA Nod for ARDS, First Allogeneic Ready-to-Use
CompanyDrug

Gene Key’s iNKT Cell Therapy Wins NMPA Nod for ARDS, First Allogeneic Ready-to-Use

SciClone's Meropenem-Vaborbactam Wins GBA Approval as First Antibiotic Under Medical Connect
CompanyDrug

SciClone’s Meropenem-Vaborbactam Wins GBA Approval as First Antibiotic Under Medical Connect

Novartis' Remibrutinib Wins NMPA Approval for Chronic Spontaneous Urticaria
CompanyDrug

Novartis’ Remibrutinib Wins NMPA Approval for Chronic Spontaneous Urticaria